| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a09910ddad885e165fd5037e36a2987 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
1993-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47b40cb4bcda9e53b352245e62c60e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6e9b51a750cb459b90bb06241c75c4 |
| publicationDate |
1995-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5438144-A |
| titleOfInvention |
Use of 1,4-dihydropyridines in diabetes |
| abstract |
The invention relates to the use of 1,4-dihydropyridines having calcium antagonistic action, in particular of nimodipine, for the preparation of medicaments for controlling damage to peripheral nerves which is caused by diabetes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004100951-A1 |
| priorityDate |
1991-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |